CONTINUE TO SITE
OR WAIT null SECS
© 2021 MJH Life Sciences™ and Modern Retina. All rights reserved.
AAO 2020: Considerations when using anti-VEGF for treating AMD
November 14, 2020
OTE Staff Reports
OTE Staff Reports
Prof. Giovanni Staurenghi, chairman of the University Eye Clinic, Department of Biomedical and Clinical Sciences at the University of Milan’s Luigi Sacco Hospital, Italy, discusses his presentation from this year's AAO, including findings from the HARBOR study of macular atrophy in AMD patients treated with ranibizumab.
Prof. Giovanni Staurenghi, chairman of the University Eye Clinic, Department of Biomedical and Clinical Sciences at the University of Milan’s Luigi Sacco Hospital, Italy, discusses his presentation from this year's AAO, including findings from the HARBOR study of macular atrophy in AMD patients treated with ranibizumab.